PRIME THERAPEUTICS for PRIME THERAPEUTICS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 954: Affordable Insulin Now Act of 2023, provisions related to cost-sharing for insulin. S. 1269: INSULIN Act of 2023, provisions related to cost-sharing for insulin. H.R. 5378: The Lower Costs, More Transparency Act, provisions related to PBM transparency. S. 2305: Biosimilar Red Tape Elimination Act, provisions related to addressing biosimilar interchangeability. H.R. 4507: Transparency in Coverage Act of 2023, provisions related to PBM transparency. H.R. 4527: Health DATA Act provisions related to plan fiduciaries access to data. H.R. 5378: The Lower Costs, More Transparency Act, Sections 105, 106, 109, 110, 202, 401, 402 and 403, provisions related to PBM transparency and disclosure. S. 127: PBM Transparency Act of 2023, provisions related to PBM disclosure and contracting arrangements. S. 1339: PBM Reform Act, provisions related to PBM disclosure and contracting arrangements.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CAROL CANTOR-WEINBERG | — |
Medicare/Medicaid MMM
H.R. 5372: Expanding Seniors Access and Lost Cost Medicines Act of 2023, provisions to set drug price cost-sharing. H.R. 5385: Medicare PBM Accountability Act, provisions related to PBM reporting requirements. H.R. 5386: Cutting Coupons Act, provisions related to cost-sharing requirements for low-income Medicare beneficiaries. H.R. 3284: Providers & Payers COMPETE Act, provisions related to consolidation. S. 2973: Modernizing and Ensuring PBM Accountability Act, provisions related to PBM regulation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE CAROL CANTOR-WEINBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.